HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Youngkeun Ahn Selected Research

No-Reflow Phenomenon

7/2016Long-Term Clinical Outcomes of Transient and Persistent No Reflow Phenomena following Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction.
5/2016Incidence, Implications, and Predictors of Stent Thrombosis in Acute Myocardial Infarction.
7/2015Role of Intravascular Ultrasound in Patients with Acute Myocardial Infarction.
8/2014The impact of no-reflow phenomena after primary percutaneous coronary intervention: a time-dependent analysis of mortality.
7/2013Impact of tissue prolapse after stent implantation on short- and long-term clinical outcomes in patients with acute myocardial infarction: an intravascular ultrasound analysis.
1/2013Comparison of triple anti-platelet therapy and dual anti-platelet therapy in patients with acute myocardial infarction who had no-reflow phenomenon during percutaneous coronary intervention.
6/2012Intravascular ultrasound findings that are predictive of no reflow after percutaneous coronary intervention for saphenous vein graft disease.
8/2011Impact of plaque components on no-reflow phenomenon after stent deployment in patients with acute coronary syndrome: a virtual histology-intravascular ultrasound analysis.
8/2009Predictors of no-reflow after percutaneous coronary intervention for culprit lesion with plaque rupture in infarct-related artery in patients with acute myocardial infarction.
8/2007Usefulness of preprocedural N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during stent implantation in patients with ST-segment elevation acute myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Youngkeun Ahn Research Topics

Disease

170Myocardial Infarction
05/2022 - 10/2006
81Cardiovascular Diseases (Cardiovascular Disease)
03/2022 - 06/2007
50Thrombosis (Thrombus)
01/2022 - 10/2006
47ST Elevation Myocardial Infarction
05/2022 - 08/2007
37Acute Coronary Syndrome
06/2022 - 04/2007
34Death (Near-Death Experience)
06/2022 - 10/2006
28Inflammation (Inflammations)
10/2021 - 12/2004
26Heart Failure
01/2022 - 08/2007
25Infarction (Infarctions)
12/2019 - 04/2003
22Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 12/2005
21Pathologic Constriction (Stenosis)
10/2021 - 12/2005
20Hyperplasia
05/2018 - 11/2005
19Hemorrhage
03/2022 - 06/2008
18Diabetes Mellitus
01/2021 - 01/2008
16Depressive Disorder (Melancholia)
01/2021 - 01/2014
16Hypertension (High Blood Pressure)
01/2020 - 01/2009
15Coronary Restenosis
10/2021 - 10/2007
13Non-ST Elevated Myocardial Infarction
05/2021 - 07/2010
12Fibrosis (Cirrhosis)
09/2021 - 01/2006
11Neointima
01/2017 - 10/2007
10Stroke (Strokes)
01/2022 - 01/2017
10Left Ventricular Dysfunction
08/2019 - 10/2006
10No-Reflow Phenomenon
07/2016 - 08/2007
9Cardiomegaly (Heart Hypertrophy)
11/2019 - 08/2003
9Prolapse
10/2013 - 07/2008
8Rupture
01/2021 - 07/2008
7Reperfusion Injury
11/2018 - 04/2003
6Vascular Calcification
03/2022 - 11/2014
6Chronic Renal Insufficiency
03/2022 - 12/2012
6Atherosclerosis
03/2022 - 05/2010
6Atrial Fibrillation
02/2020 - 08/2007
6Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2018 - 01/2011
5Anemia
05/2022 - 07/2011
5Spasm (Spasms)
01/2022 - 10/2010
5Myocardial Ischemia (Ischemic Heart Diseases)
01/2021 - 12/2005
5Neoplasms (Cancer)
07/2020 - 11/2012
5Ischemia
09/2018 - 12/2004
5Hypertrophy
01/2018 - 08/2003
5Atherosclerotic Plaque (Atheroma)
01/2017 - 09/2010
4Overweight
07/2022 - 11/2010
4Cardiogenic Shock
06/2021 - 09/2011
4Hypercholesterolemia
01/2021 - 10/2016
4Breast Neoplasms (Breast Cancer)
07/2020 - 12/2016
4Pulmonary Embolism
11/2019 - 01/2011
4Dyslipidemias (Dyslipidemia)
01/2019 - 06/2012
4Body Weight (Weight, Body)
01/2019 - 05/2014
4Stable Angina
05/2017 - 04/2009

Drug/Important Bio-Agent (IBA)

75omega-Chloroacetophenone (Mace)IBA
03/2022 - 10/2006
29Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 12/2005
18C-Reactive ProteinIBA
01/2022 - 12/2005
13EscitalopramFDA Link
01/2021 - 01/2014
12LDL CholesterolIBA
05/2022 - 10/2010
10FibrinIBA
10/2021 - 06/2006
10Rosuvastatin Calcium (Crestor)FDA Link
01/2021 - 06/2007
10LipidsIBA
01/2021 - 07/2010
10Brain Natriuretic Peptide (Natrecor)FDA Link
08/2017 - 12/2005
9CreatinineIBA
07/2022 - 04/2010
9oxidized low density lipoproteinIBA
05/2022 - 01/2011
9Clopidogrel (Plavix)FDA Link
03/2022 - 10/2009
9EverolimusFDA Link
10/2021 - 12/2012
9PolymersIBA
10/2021 - 09/2009
9MetalsIBA
01/2021 - 12/2009
9zotarolimusIBA
08/2019 - 01/2011
8Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2011
8Paclitaxel (Taxol)FDA LinkGeneric
01/2017 - 01/2011
7CalciumIBA
03/2022 - 07/2010
7Angiotensin Receptor AntagonistsIBA
01/2022 - 04/2013
7TicagrelorIBA
11/2021 - 07/2016
7pro-brain natriuretic peptide (1-76)IBA
08/2017 - 12/2005
6Hemoglobins (Hemoglobin)IBA
05/2022 - 03/2011
6Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2022 - 04/2009
6Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2022 - 12/2015
6Abciximab (ReoPro)FDA Link
06/2018 - 10/2007
6Sirolimus (Rapamycin)FDA Link
04/2016 - 06/2007
5Ergonovine (Ergometrine)IBA
01/2022 - 10/2009
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 08/2003
5Ezetimibe (Zetia)FDA Link
01/2021 - 05/2010
5HDL CholesterolIBA
05/2020 - 04/2012
5Pharmaceutical PreparationsIBA
01/2020 - 12/2014
5Amlodipine (Norvasc)FDA LinkGeneric
09/2019 - 01/2015
5Cilostazol (Pletal)FDA LinkGeneric
01/2015 - 01/2008
4Biological ProductsIBA
01/2022 - 11/2016
4Proteins (Proteins, Gene)FDA Link
09/2021 - 01/2006
4Angiotensin IIIBA
01/2021 - 01/2006
4Indicators and Reagents (Reagents)IBA
05/2020 - 06/2009
4Warfarin (Coumadin)FDA LinkGeneric
02/2020 - 10/2015
4TroponinIBA
11/2019 - 12/2013
4fimasartanIBA
09/2019 - 01/2015
4Glucose (Dextrose)FDA LinkGeneric
09/2019 - 08/2014
4EnzymesIBA
01/2019 - 12/2005
4BESIBA
01/2018 - 11/2013

Therapy/Procedure

129Percutaneous Coronary Intervention
03/2022 - 10/2006
89Stents
01/2022 - 11/2005
41Therapeutics
01/2022 - 12/2004
37Drug-Eluting Stents
08/2021 - 10/2007
20Coronary Artery Bypass (Coronary Artery Bypass Surgery)
05/2020 - 05/2009
5Secondary Prevention
05/2022 - 02/2013
5Patient Readmission
01/2022 - 09/2015
5Cell- and Tissue-Based Therapy (Cell Therapy)
01/2019 - 09/2013
4Transplantation
12/2019 - 01/2014